If you’re searching for a ketamine nasal spray for depression, you may be feeling tired, discouraged or unsure what to try next. When depression has not improved enough with the care you have already tried, looking for another option can bring both hope and hesitation.
The prescription treatment that many people mean is Spravato® (esketamine) nasal spray. This guide is here to help you understand whether Spravato belongs in a conversation with your clinician.
This is not a dense science article or a step-by-step session walkthrough. We’ll stay focused on what Spravato is, who it may be considered for, what the time commitment can look like and what questions may help you feel steadier before you make a decision.
A quick name clarification
The language around ketamine treatment can get confusing fast, especially when you are already carrying the weight of depression.
Ketamine is a medication that has been used in medicine for decades. In mental health care, you may hear about ketamine given in different ways, including IV ketamine in some clinics.
Esketamine is one form of ketamine. It is not a nickname. It is a specific version of the medication.
Spravato is the brand-name product that contains esketamine. It is prescribed and administered as a nasal spray in a monitored clinical setting.
People still search for “ketamine nasal spray” because ketamine is the broader term they have heard. In practice, the FDA-approved esketamine nasal spray for certain depression indications is Spravato.
From here, we’ll mostly use Spravato for clarity while still including the terms you may see during your own research.
What Spravato is in practical terms
Spravato is a prescription treatment given as a nasal spray in a certified clinic, where trained staff monitor you afterward. You do not take it home or use it on your own schedule.
Spravato may be used alongside an oral antidepressant or, for TRD, as a standalone treatment. For depressive symptoms in adults with MDD with acute suicidal ideation or behavior, it is used in conjunction with an oral antidepressant. Your clinician will help determine the right combination and follow-up plan for your diagnosis, history and current needs.
Because Spravato can cause short-term effects like sedation, dissociation or changes in blood pressure, your care team monitors you during and after dosing. That monitoring can make the treatment feel more predictable, and knowing what to expect often helps reduce anxiety before the first visit.
How Spravato compares with IV ketamine and daily antidepressants
Spravato, IV ketamine and traditional antidepressants can all come up in conversations about depression treatment. They are not the same.
Spravato is an FDA-approved nasal spray containing esketamine. It is administered in a clinic with required safety steps and monitoring.
IV ketamine for depression is often offered off-label. It uses a different route, and protocols can vary from one setting to another. Some people explore it when weighing their options, but it is not the same treatment as Spravato.
Traditional daily antidepressants are often used earlier in depression care. Many people do well with them, though they may take weeks to show benefit. When those treatments do not bring enough relief, the conversation may expand to other strategies.
The next step is a thoughtful conversation with a clinician who can look at your symptoms, treatment history, medical risks and what you can realistically manage right now.
Who is ketamine nasal spray for depression considered for?
Spravato is often considered when depression has been hard to improve with other treatments. For many people, that point comes after therapy, medication or both have not brought the relief they were hoping for.
Clinicians often use the term treatment-resistant depression when someone has had an inadequate response to at least two antidepressant trials. You may also see the acronym TRD in medical records, insurance forms or clinic paperwork.
Diagnosis matters as well. Spravato is used within specific diagnostic contexts, including major depressive disorder. Your clinician may use MDD as shorthand, then talk with you in more personal detail about your symptoms, your functioning and how depression is affecting daily life.
Eligibility is determined by your prescriber after reviewing your treatment history, current depression severity, safety considerations and diagnostic criteria like MDD or TRD. You do not have to decide alone whether you “qualify.” Your clinician can help you understand whether this treatment fits your needs and risks.
Think of the conversation less like a test and more like a careful fit check.
Health factors your clinician may want to review
Some health factors call for a slower, more careful discussion before moving forward. That does not automatically mean Spravato is off the table. It means your care team wants to plan for safety and comfort.
Your clinician may want more detail if you have a history of blood pressure concerns or strong reactions to sedation during medications or procedures.
Bring a full medication list, including supplements. Complex medication combinations can change what your team needs to monitor.
If you have concerns about substance use or a history of dissociation, panic or intense anxiety about altered states, bring that up early. A good clinic will take those concerns seriously and talk with you about support, pacing and what can help you feel grounded.
How Spravato works in simple terms
Spravato works as an NMDA receptor antagonist. In plain language, it blocks the NMDA receptor and triggers downstream changes in glutamate signaling in the brain. That differs from many standard antidepressants, which focus more on serotonin or norepinephrine.
For some people, the practical difference is that changes may be noticed more quickly than with past approaches. That may feel like a softening in mood intensity, a little more flexibility in your thinking or an easier time getting through the day.
Response varies. Some people notice change early, some notice it later and some do not respond enough to keep going. Monitoring and follow-up help your clinician understand how the treatment is affecting you.
If you want to look at how Spravato has been studied in controlled settings, you can review the results of randomized clinical trials and talk with your prescriber about what those findings may mean for your situation.
What the treatment journey generally looks like
Spravato care has a rhythm that affects real life. Time, rides and recovery planning can matter just as much as the medication itself.
Before treatment, you’ll have an evaluation that covers your diagnosis, symptom history, previous treatments, medical history and current medications. You’ll also plan transportation because driving restrictions apply after dosing.
During treatment, you receive Spravato in the clinic under supervision. Staff monitors you during an observation period for effects like sedation, dissociation and changes in blood pressure.
After treatment, most people go home with a ride and keep the rest of the day light. Your team may ask you to track symptoms and functioning between visits, not just how you feel on treatment days.
Two friction points come up again and again. The visits take time, and you cannot drive yourself home.
Plan on arranging a ride each time. You should also avoid safety-sensitive tasks the same day. Your clinic will give guidance that aligns with the prescribing information and your response during treatment.
Planning for time, rides and the observation period
Clinics monitor for short-term effects, which can include sedation, temporary increases in blood pressure, dizziness and dissociation. Even when you expect those effects, they can feel unfamiliar in the moment.
Driving is one of the biggest planning pieces. Many clinics advise that you should not drive or operate machinery until the day after a restful night’s sleep. You can read that directly in the SPRAVATO prescribing information.
A little planning can make treatment days feel less stressful:
If you have been pushing through depression alone for a long time, accepting help may feel uncomfortable. With Spravato, help with logistics is part of making the treatment workable.
What people hope will change
People rarely pursue Spravato because they want a new medication experience. They pursue it because they want parts of their life back.
One hope is symptom relief. That may mean less intense sadness, less dread or fewer spikes of despair. Some people describe the emotional weight lifting enough to breathe, think and move through the day with a little more room inside.
Another hope is improved functioning. Getting out of bed, returning messages, making it to work or staying present in a conversation can become meaningful signs of progress.
Quality of life matters too. Sleep may feel less chaotic. Motivation may return in short bursts. The ability to feel pleasure may begin to reappear.
Progress is tracked over time. One good day or one hard day rarely tells the full story. Clinics often use symptom scales along with your own goals to judge whether Spravato is earning its place in your treatment plan.
What “rapid relief” can realistically mean
When people say Spravato may work rapidly, they often mean faster than the timeline they have lived through with other medications. Some people notice changes within hours to days. Others need more time, and some do not experience enough benefit to continue.
Early signs may feel quieter than you hoped, yet still meaningful. You may notice depressive symptoms soften or basic tasks take less effort.
Some people notice less cognitive rigidity, so problems feel less permanent. Others notice sleep or appetite stabilizing first. Your clinician can help you track what is changing instead of forcing you to answer whether you feel “fixed.”
Spravato may be used alongside an oral antidepressant or, for TRD, as a standalone treatment with follow-up visits. The medication may open a window, while ongoing care helps you use that window to rebuild steadier routines and support.
Limits and trade-offs to weigh
Spravato asks for time. Clinic visits, monitoring and ride planning can be hard if you are already stretched thin, working, caregiving or trying to keep life together while depressed.
It also asks for emotional bandwidth. Starting something new can bring hope, followed by fear of disappointment. If decision fatigue is high, extra support can help the plan feel more manageable.
Side effects are another trade-off. Many effects are short-term, but they can still feel uncomfortable. You and your clinician should have a clear plan for what to do if side effects feel too intense.
Response is not guaranteed. A fit check can include two honest questions: “If this helps some, what would enough look like for me?” and “If it does not help, what is our next plan?”
Side effects and safety monitoring
Most safety conversations come down to two areas: what you may feel during or after a visit, and what staff are watching to help keep you safe.
Common short-term effects can include dissociation, sedation, dizziness, nausea and temporary increases in blood pressure. Clinics plan for these effects, which is one reason Spravato is given in a clinic instead of at home.
Staff monitors your vitals, mental status and readiness to leave with your ride. They also watch for worsening anxiety, unusual confusion or anything that suggests you need more time before discharge.
Spravato is available only through a safety program that sets requirements for certified treatment sites. You can read more about the Spravato REMS program and bring questions to your clinic.
Common short-term effects during or after visits
People often describe the experience as different, not necessarily bad. Still, knowing what may come up can help you feel more prepared.
Your team can talk with you about pacing, coping skills during the visit and what helps you feel grounded afterward.
Call your clinic if you have persistent or concerning symptoms after you get home, a severe headache, chest pain, intense or prolonged confusion, worsening depressive symptoms or questions about medication interactions. If something feels alarming, trust that instinct and seek urgent care.
Cost and insurance questions to ask
Financial stress can make depression feel heavier. Clear answers help, even when the first answer is “we need to check.”
These questions can move the process forward:
Your clinic and insurer can give specifics for your coverage. If you are helping a loved one, ask what paperwork they need to sign so you can support the calls.
Whole-person care alongside Spravato
Medication can reduce symptoms, but day-to-day life still needs structure and support. A whole-person plan looks at brain and body together without blaming you for being depressed.
Sleep is often an early focus because sleep loss can intensify mood symptoms and stress reactivity. Nutrition and hydration can support steadier energy, which may make treatment days easier.
Movement helps many people regulate stress, even when it is gentle and brief. Mindfulness or grounding practices can reduce fear if dissociation feels unsettling.
Relationships matter too. Depression can shrink your world, and rebuilding connection often takes care, patience and support. Psychotherapy, including trauma-informed care, can help you understand patterns that medication alone cannot fully address.
At Memor Health, we treat Spravato as one tool inside a broader plan that supports your nervous system, your routines and your ability to stay connected to the people and practices that help you heal.
Questions to ask your provider before you start
Having questions does not make you difficult. Questions can help you feel steadier in a process that may feel vulnerable.
Consider asking:
If you struggle to remember details during appointments, ask whether you can bring a support person or write your questions down ahead of time.
Finding a treatment center and common concerns
Spravato is administered in certified settings with monitoring requirements. That structure is part of why it is not dispensed like a routine prescription.
When you call a clinic, ask if they are certified under REMS requirements and how they handle observation and discharge readiness. You are listening for clarity, not perfection.
If you are in northern Nevada, Memor Health serves the Reno, NV area. Availability, scheduling and fit depend on clinical evaluation and capacity, so a phone screening is often the first step.
Avoid sourcing any prescription spray online. Counterfeit or improperly handled medications carry real risk, and they bypass the monitoring that makes this treatment safer.
FAQ
How long do visits take?
Plan for a clinic visit that includes dosing and an observation period, along with time for check-in and safe discharge. Your clinic will tell you the expected time block.
Can you drive after Spravato?
No. Plan a ride home and avoid driving until the next day after a restful night’s sleep, following clinic guidance and prescribing information.
Why does the observation period exist?
The observation period gives staff time to monitor blood pressure, sedation, dissociation and recovery readiness before you leave.
How does Spravato relate to ketamine?
Spravato contains esketamine, which is one form of ketamine. The route, regulation and indications differ from other ketamine treatments.
What does dissociation mean?
Dissociation is a temporary feeling of detachment, altered perception or mental distance. Clinics monitor it and help you stay grounded.
What does TRD mean?
TRD is shorthand for treatment-resistant depression. Clinicians use it when standard treatments have not helped enough after at least two attempts.
Glossary
Ketamine: A medication used in medicine for decades. It is sometimes used off-label for depression.
Esketamine: One form of ketamine used in Spravato.
Spravato: Brand-name esketamine product administered in a certified clinic with monitoring.
Esketamine nasal spray: The intranasal form used in Spravato treatment sessions.
Intranasal: Given through the nose, not swallowed as a pill or delivered through an IV.
TRD: Acronym for treatment-resistant depression.
Treatment-resistant depression: Depression that has not improved enough after at least two adequate antidepressant treatment attempts.
Major depressive disorder: A clinical diagnosis of depression that affects mood, thinking and daily functioning.
MDD: Abbreviation for major depressive disorder.
Depressive symptoms: Signs like low mood, loss of interest, sleep changes, low energy and hopelessness.
Dissociation: A short-term altered sense of perception or detachment that may occur during treatment.
Observation period: The monitored time after dosing that supports safety and recovery readiness.
Antidepressant: A medication used to treat depression. Spravato for TRD may be used with or without an oral antidepressant. For MDD with acute suicidal ideation or behavior, it is used with an oral antidepressant.
NMDA/glutamate: A brain signaling pathway that Spravato affects, distinct from many standard antidepressants.
A steadier next step
If you are weighing Spravato, you do not need to decide everything at once. Start with a fit check: your diagnosis, treatment history, medical risks and capacity for visits and rides. A calm conversation with a qualified prescriber can help you decide whether ketamine nasal spray for depression is the right next step for you or whether a different plan fits better right now.
|
Common concern |
What to do next |
|
Suicidal ideation |
If you feel at risk right now, contact local emergency services or the 988 Suicide & Crisis Lifeline for immediate support. |
|
Pregnancy |
Tell your prescriber right away if you are pregnant, trying to conceive or breastfeeding so risks and alternatives can be reviewed. |
|
Online purchasing or sourcing safety |
Do not purchase Spravato or ketamine products online. Use only certified clinical care pathways with monitoring. |
